| 1 | EXAS | Exact Sciences Corporation | 4.94% |
| 2 | ILMN | Illumina, Inc. | 4.08% |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 3.95% |
| 4 | KRYS | Krystal Biotech, Inc. | 3.95% |
| 5 | NTRA | Natera, Inc. | 3.92% |
| 6 | ACAD | ACADIA Pharmaceuticals Inc. | 3.91% |
| 7 | BRKR | Bruker Corporation | 3.86% |
| 8 | VCYT | Veracyte, Inc. | 3.47% |
| 9 | EXEL | Exelixis, Inc. | 3.44% |
| 10 | BIIB | Biogen Inc. | 3.43% |
| 11 | INCY | Incyte Corporation | 3.39% |
| 12 | WAT | Waters Corporation | 3.31% |
| 13 | MRNA | Moderna, Inc. | 3.30% |
| 14 | UTHR | United Therapeutics Corporation | 3.27% |
| 15 | AMGN | Amgen Inc. | 3.26% |
| 16 | BMRN | BioMarin Pharmaceutical Inc. | 3.25% |
| 17 | RGEN | Repligen Corporation | 3.25% |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 3.22% |
| 19 | CORT | Corcept Therapeutics Incorporated | 3.17% |
| 20 | MTD | Mettler-Toledo International Inc. | 3.17% |
| 21 | HALO | Halozyme Therapeutics, Inc. | 3.05% |
| 22 | GILD | Gilead Sciences, Inc. | 3.02% |
| 23 | NBIX | Neurocrine Biosciences, Inc. | 3.02% |
| 24 | ARGX | argenx SE | 3.01% |
| 25 | GMAB | Genmab A/S | 2.98% |
| View FBT holdings |
